Cargando…
Mass Spectrometry-Based Proteomics: Analyses Related to Drug-Resistance and Disease Biomarkers
Mass spectrometry-based proteomics is a key player in research efforts to characterize aberrant epigenetic alterations, including histone post-translational modifications and DNA methylation. Data generated by this approach complements and enrich datasets generated by genomic, epigenetic and transcr...
Autores principales: | Agostini, Marco, Traldi, Pietro, Hamdan, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608342/ https://www.ncbi.nlm.nih.gov/pubmed/37893440 http://dx.doi.org/10.3390/medicina59101722 |
Ejemplares similares
-
Mass Spectrometry Contribution to Pediatric Cancers Research
por: Agostini, Marco, et al.
Publicado: (2023) -
Protein Glycation in Diabetes as Determined by Mass Spectrometry
por: Lapolla, Annunziata, et al.
Publicado: (2013) -
Mass Spectrometry for Diabetic Nephropathy Monitoring: New Effective Tools for Physicians
por: Lapolla, Annunziata, et al.
Publicado: (2012) -
Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics
por: Liu, Yahui, et al.
Publicado: (2014) -
Mass spectrometry-based proteomic analyses of contact lens deposition
por: Green-Church, Kari B., et al.
Publicado: (2008)